5R5-25992-29241
2 vaccinations
2 coded responses
15 check-ins
2 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 208 / MD
- Registered
- 2022-06-23
- Relationship
- Child or adolescent in my care
- Guardian
- UTD-28724-11631
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-23
Registered in v-safe
-
2022-06-23
Dose 1 — Pfizer-BioNTech
- 2022-06-24
-
2022-06-25
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Fair · Sleepiness, Irritability/cryingUnder 3 check-in
- 2022-06-26
- 2022-06-27
- 2022-06-28
- 2022-06-29
- 2022-06-30
-
2022-07-09
Survey response — day 14, dose 1, under 3MedDRA: Cough, Rhinorrhoea — Feeling: GoodFree text: Runny nose and coughMedDRA releases: 2024-11 · check-in free text available
- 2022-07-14
- 2022-07-23
-
2022-08-03
Dose 2 — Pfizer-BioNTech
- 2022-08-11
- 2022-08-19
-
2022-08-24
Survey response — day 21, dose 2, under 3MedDRA: Cough, Rhinorrhoea — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Runny nose and coughMedDRA releases: 2024-11 · check-in free text available
-
2022-08-24
Report sent to call center — day 21, dose 2, under 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-08-25
-
2022-08-29
Call successfulNot applicable - Accidental Reporting
- 2022-09-14
- 2022-11-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-23 | Pfizer-BioNTech | No |
| 2 | 2022-08-03 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-08-24 | Successful 2022-08-29 |
Not applicable - Accidental Reporting |
Free text
Release 12 (Under 3) — day 14, dose 1, under 3
Symptoms: Runny nose and cough
Release 12 (Under 3) — day 21, dose 2, under 3
Symptoms: Runny nose and cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release